The Niti Aayog on Wednesday held a meeting with the captains of industry in the pharmaceutical sector to discuss the impact of disruption in supplies of active pharmaceutical ingredients (APIs) following the coronavirus outbreak in China.
According to sources, hosts of measures were discussed aimed at boosting domestic manufacturing of APIs to reduce dependence on imports of the APIs from China.
The meeting was chaired by Niti Aayog CEO Amitabh Kant and attended by Pharmaceutical Department Secretary P D Vaghela and Biocon Chairperson and Managing Director Kiran Mazumdar Shaw, among others.
"Fruitful, constructive & positive meeting with captains of industry in pharmaceutical sector to discuss the options for domestic manufacturing of critical APIs on which India is import dependent. Consensus arrived at on a range of policy measures for creating ecosystem in India," Kant said in a tweet after the meeting.
According to the sources, Kant told industry captains that they should try .
